Adiponectin as a Potential Biomarker for Pregnancy Disorders

Area of Science:

• Endocrinology
• Reproductive Medicine
• Metabolic Health

Background:

• Adiponectin is an adipocyte-derived hormone crucial for energy homeostasis and insulin sensitivity.
• Decreased adiponectin levels are linked to metabolic diseases like obesity and type 2 diabetes.
• Emerging evidence suggests adiponectin's potential as a biomarker for pregnancy complications.

Purpose of the Study:

• To review the role of adiponectin as a potential biomarker for pregnancy disorders.
• To highlight studies investigating adiponectin's utility in predicting gestational diabetes mellitus, preeclampsia, preterm birth, and abnormal intrauterine growth.

Main Methods:

• Literature review of studies examining adiponectin levels in relation to pregnancy complications.
• Analysis of existing research on adiponectin's diagnostic and prognostic value in common pregnancy disorders.

Main Results:

• Adiponectin levels are frequently altered in conditions such as gestational diabetes mellitus, preeclampsia, preterm birth, and abnormal intrauterine growth.
• Studies indicate a correlation between reduced adiponectin and increased risk or severity of these pregnancy complications.

Conclusions:

• Adiponectin holds significant potential as a predictive biomarker for various pregnancy complications.
• Further research is recommended to establish standardized protocols for adiponectin measurement and clinical application in high-risk pregnancies.